Valuation: Epigral Limited

Market Cap 51.89B 542M 464M 434M 397M 750M 757M 5.14B 2B 26.05B 2.03B 1.99B 86.2B P/E 2027 *
15x
P/E 2028 * 11.8x
Enterprise Value 57.8B 604M 517M 484M 442M 835M 844M 5.73B 2.23B 29.02B 2.27B 2.22B 96.03B EV / Sales 2027 *
1.87x
EV / Sales 2028 * 1.54x
Free-Float
31.14%
Yield 2027 *
0.46%
Yield 2028 * 0.46%
1 day+6.81%
1 week+9.50%
Current month+10.47%
1 month+4.40%
3 months-3.87%
6 months+24.76%
Current year-1.43%
1 week 1,054.6
Extreme 1054.6
1,228.3
1 month 1,054.6
Extreme 1054.6
1,228.3
Current year 807
Extreme 807
1,400
1 year 807
Extreme 807
1,850
3 years 807
Extreme 807
2,406.75
5 years 493.95
Extreme 493.95
2,406.75
10 years 387.1
Extreme 387.1
2,406.75
Manager TitleAgeSince
Chief Executive Officer 41 -
Director of Finance/CFO - 2025-11-09
Compliance Officer - 2024-04-21
Director TitleAgeSince
Director/Board Member 61 2021-05-24
Chairman 43 -
Director/Board Member 39 2016-05-09
Change 5-day change 1-year change 3-year change Capi.($)
+6.81%+9.50%-34.82%+35.37% 508M
+0.35%+0.53%+2.10%+24.72% 124B
-6.25%-13.25%+337.96%+174.81% 47.82B
+1.60%+1.49%-17.69%-42.10% 40.07B
-1.07%+0.21%+8.96%-19.98% 34.45B
-3.49%+1.44%+42.72%+73.67% 26.03B
-2.40%+1.07%+14.67%-32.75% 21.81B
-0.58%+9.52%+9.71%+32.67% 19.76B
-0.80%+8.42%+36.23%+17.88% 19.59B
-1.77%-4.19%+313.28%+580.40% 19.16B
Average -0.76%+1.33%+71.31%+84.47% 35.34B
Weighted average by Cap. -1.21%-0.86%+68.88%+63.37%

Financials

2027 *2028 *
Net sales 30.88B 322M 276M 259M 236M 446M 451M 3.06B 1.19B 15.5B 1.21B 1.18B 51.3B 37.28B 389M 334M 312M 285M 538M 544M 3.69B 1.44B 18.72B 1.46B 1.43B 61.93B
Net income 3.47B 36.19M 31.02M 29.02M 26.53M 50.06M 50.59M 343M 134M 1.74B 136M 133M 5.76B 4.4B 45.92M 39.35M 36.82M 33.66M 63.52M 64.19M 436M 169M 2.21B 172M 169M 7.31B
Net Debt 5.92B 61.79M 52.95M 49.54M 45.29M 85.47M 86.38M 586M 228M 2.97B 232M 227M 9.83B 5.49B 57.32M 49.12M 45.95M 42.01M 79.28M 80.13M 544M 211M 2.76B 215M 211M 9.12B
Logo Epigral Limited
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Employees
1,135
Date Price Change Volume
26-08-23 1,202.70 +6.81% 360,212
26-08-21 ₹1,126.00 +0.49% 29,039
26-08-20 ₹1,120.50 +3.54% 240,958
26-08-19 ₹1,082.20 +0.24% 118,759
26-08-18 ₹1,079.60 -1.60% 38,584
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,202.70INR
Average target price
1,728.00INR
Spread / Average Target
+43.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EPIGRAL Stock